Creatine Beyond Muscle: Brain Health, Mitochondria, and Aging (2026)

Your brain weighs about 2% of your body mass. It consumes roughly 20% of your total energy output. And when it runs low on ATP (adenosine triphosphate – your cells' primary energy currency), cognitive function does not gradually dim. It drops sharply: slower processing speed, impaired working memory, worse decision-making under pressure, and reduced resilience to stress.

This is not a theoretical problem. Sleep one bad night, skip meals, endure chronic psychological stress, or simply age past 50 – and your brain's ATP turnover rate outpaces its regeneration capacity. The result is a measurable cognitive deficit that most people attribute to "getting older" or "not being a morning person."

There is a molecule that directly buffers this energy gap. It is the single most studied sports supplement in human history, with over 500 clinical trials spanning five decades. It costs less per month than a streaming subscription. And most people still think it is only for bodybuilders.

Creatine monohydrate.

The gym bro reputation is not wrong – creatine does enhance muscle performance. But it is incomplete in a way that has hidden one of the most compelling longevity compounds in plain sight. The phosphocreatine system does not care whether the ATP it replenishes is in a bicep or a prefrontal cortex. It works wherever cells need rapid energy, and the organs that need it most – brain, heart, skeletal muscle – are precisely the ones that deteriorate fastest with age.

This article covers the full picture: the energy system nobody explained to you, the brain data that changes the conversation, and why creatine may matter more after 50 than it ever did at 25.

TL;DR – Key Takeaways

• Creatine is not just a muscle supplement – it is a cellular energy buffer that operates in every high-energy-demand tissue, especially the brain
• The phosphocreatine system rapidly regenerates ATP during periods of high demand, acting as a "battery backup" for cells
• Meta-analysis (Avgerinos et al., 2018): creatine supplementation improves short-term memory and reasoning, especially under conditions of stress or sleep deprivation
• Combined with resistance training, creatine is the strongest evidence-based intervention for age-related muscle loss (Chilibeck et al., 2017 meta-analysis)
• The creatine kinase shuttle maintains mitochondrial membrane potential – a direct link to cellular energy production
• Emerging evidence for bone density benefits in postmenopausal women and anti-inflammatory effects via homocysteine reduction
• In the GLP-1 drug era, creatine's muscle-preserving properties take on new relevance for people losing lean mass alongside fat
• Dose: 3–5 g/day of creatine monohydrate. No loading phase required. Extremely safe across 500+ studies
• Cost: roughly $0.10–0.15/day – one of the cheapest effective interventions in all of supplement science

Quick Facts: Creatine

• Dose: 3-5 g/day
• Form: Creatine monohydrate (no alternative form has proven superior)
• Timing: Any time, consistently
• Evidence: Strong (500+ RCTs, ISSN endorsed)
• Who it's for: Everyone over 30 -- especially older adults, vegetarians, and anyone doing resistance training

What Is Creatine (And Why Its Reputation Is Stuck in the 1990s)

Creatine is a naturally occurring compound synthesized from three amino acids – arginine, glycine, and methionine – primarily in the liver and kidneys. About 95% of the body's creatine is stored in skeletal muscle, with the remaining 5% distributed across the brain, heart, kidneys, and testes.

You also get creatine from food. Red meat and fish are the primary dietary sources – a pound of raw beef contains roughly 2 grams. Vegetarians and vegans have measurably lower baseline creatine stores, which becomes relevant when we discuss brain effects.

Here is the critical point that most coverage misses: creatine is not a stimulant, not a hormone, and not an anabolic steroid. It is a substrate – a raw material that your cells use to maintain their energy reserves. Calling creatine a "gym supplement" is like calling oxygen a "running aid." Technically true. Fundamentally misleading.

The molecule was discovered in 1832 by French chemist Michel Chevreul, who isolated it from meat (the name derives from the Greek kreas, meaning flesh). Its role in muscle bioenergetics was understood by the mid-20th century. Supplementation research exploded in the early 1990s after Roger Harris published the landmark study showing that oral creatine monohydrate increased intramuscular phosphocreatine stores by 20% (Harris et al., Clinical Science, 1992).

Since then, over 500 peer-reviewed studies have been conducted. The International Society of Sports Nutrition (ISSN) considers creatine monohydrate the most effective ergogenic (performance-enhancing) nutritional supplement available to athletes (Kreider et al., JISSN, 2017). But what the sports nutrition community has known for decades, the longevity community is only now catching up to: creatine's mechanism of action is not muscle-specific. It is energy-specific. And aging is, at its core, an energy crisis.

The Phosphocreatine Energy System: Your Cellular Battery Backup

To understand why creatine matters for aging, you need to understand the phosphocreatine system – also called the creatine kinase/phosphocreatine system (CK/PCr system).

ATP is the universal energy currency of your cells. Every muscle contraction, every neurotransmitter release, every ion pump that maintains your heartbeat – all of it runs on ATP. The problem is that cells do not store much ATP at any given moment. A resting muscle cell has enough ATP for roughly 2–3 seconds of maximal effort. Your brain turns over its entire ATP pool approximately every 5–10 seconds during normal function.

This is where phosphocreatine (PCr) comes in. Phosphocreatine is creatine with a high-energy phosphate group attached to it. When ATP is consumed (converted to ADP – adenosine diphosphate, the "spent" form of ATP), the enzyme creatine kinase instantly transfers that phosphate from PCr to ADP, regenerating ATP. This reaction happens in milliseconds – far faster than mitochondria can produce new ATP through oxidative phosphorylation (the multi-step process in mitochondria that generates ATP from nutrients and oxygen).

Think of it this way: mitochondria are your power plant. They produce energy continuously but cannot surge instantly. Phosphocreatine is your battery backup – it absorbs demand spikes and prevents brownouts. When you sprint, your muscles use phosphocreatine to fuel the first 8–10 seconds before aerobic metabolism catches up. When your brain solves a complex problem under time pressure, the same system buffers the ATP demand surge in prefrontal cortex neurons.

The creatine kinase reaction is reversible. When energy supply exceeds demand (at rest), mitochondria produce excess ATP, and creatine kinase runs in reverse – recharging creatine back to phosphocreatine. This cycle – charge, discharge, recharge – runs continuously in every metabolically active cell in your body.

Here is the aging problem: as mitochondrial function declines with age (a well-documented phenomenon – see The Mitochondrial Theory of Aging for the full picture), the ability to recharge the phosphocreatine buffer slows. Simultaneously, total creatine stores decline. The result is a shrinking energy buffer in organs that depend on it most. Supplementing creatine increases the total pool available for this buffering system – not by making mitochondria work harder, but by giving them more raw material to work with.

Brain and Cognitive Benefits: The Data That Changes Everything

The brain is the most energy-demanding organ in the body per unit mass. It cannot store glycogen (stored glucose) in meaningful quantities. It cannot burn fat directly. It relies almost entirely on a continuous supply of glucose and oxygen to drive mitochondrial ATP production – and on the phosphocreatine system to buffer moment-to-moment fluctuations.

Brain creatine levels are not trivial. The brain synthesizes some creatine locally, but also imports it from the bloodstream via the creatine transporter (SLC6A8). Genetic defects in this transporter cause creatine transporter deficiency – a condition characterized by intellectual disability, seizures, and severe speech and language impairment. This is not a subtle phenotype. It tells you exactly how dependent the brain is on adequate creatine.

Andrew Huberman takes 5g creatine monohydrate daily as one of his core foundational supplements, and he has been vocal about creatine's cognitive benefits – particularly under sleep deprivation or high cognitive load – not just its muscle effects. Peter Attia also takes creatine, viewing it as one of the few supplements with unambiguous evidence for both muscle preservation and brain health. When two of the most rigorous voices in the longevity space agree on a supplement, it is worth paying attention to the data behind their reasoning.

The Avgerinos Meta-Analysis (2018)

The most cited evidence for creatine's cognitive effects comes from a systematic review and meta-analysis by Avgerinos and colleagues, published in Experimental Gerontology (Avgerinos et al., 2018; PMID 29704637). The analysis pooled six randomized controlled trials (RCTs – studies where participants are randomly assigned to receive either the treatment or a placebo, the gold standard of clinical evidence) examining creatine supplementation and cognitive function in healthy individuals.

Key findings:

• Short-term memory and reasoning were significantly improved in creatine-supplemented groups compared to placebo
• The effects were most pronounced under conditions of cognitive stress – sleep deprivation, mental fatigue, and time pressure
• Older adults showed larger effect sizes than younger adults, consistent with the hypothesis that lower baseline creatine stores create more room for improvement
• Vegetarians showed particularly strong responses, likely because their baseline brain creatine levels are lower due to absence of dietary creatine from meat

A 2022 study by Forbes and colleagues expanded on this, finding that creatine supplementation improved memory performance across multiple domains, with effects particularly robust in adults over 66 (Forbes et al., Nutrition Reviews, 2022; PMID 36220764).

Sleep Deprivation and Cognitive Rescue

One of the most striking applications of creatine is its ability to partially rescue cognitive performance during sleep deprivation. McMorris et al. (2006) showed that creatine supplementation (20 g/day for 7 days, then testing after 24 hours of sleep loss) significantly attenuated the decline in complex executive function tasks – specifically random number generation and mood state – compared to placebo (McMorris et al., Psychopharmacology, 2006; PMID 16826400).

A follow-up study by McMorris et al. (2007) confirmed that creatine loading mitigated the decline in complex central executive tasks after 36 hours of sleep deprivation, though simpler tasks were unaffected (PMID 17191018). The interpretation: creatine specifically supports the most energy-demanding cognitive operations – the ones that fail first when energy supply is compromised.

For shift workers, new parents, frequent travelers, or anyone whose sleep is regularly disrupted, this is a practical finding with immediate relevance.

Key Takeaway: Creatine significantly improves short-term memory and reasoning — especially in older adults, vegetarians, and people under cognitive stress like sleep deprivation. At 5g/day, it is one of the most affordable and well-validated cognitive supplements available. If your sleep is ever compromised, creatine provides measurable neuroprotection.

How creatine monohydrate compares to alternative forms:

Neuroprotection: TBI and Neurodegeneration

Preclinical evidence for creatine's neuroprotective effects is substantial, though human translation is still in progress.

Traumatic brain injury (TBI). In animal models, creatine supplementation before or after TBI reduces cortical damage by 36–50%, preserves mitochondrial function, and improves neurological outcomes (Sullivan et al., Annals of Neurology, 2000; PMID 10976075). A pilot human study in children and adolescents with TBI (Sakellaris et al., 2006) found that creatine supplementation reduced post-traumatic headache, dizziness, and fatigue, and improved cognitive and behavioral outcomes during a 6-month follow-up (PMID 16679861).

Neurodegenerative disease models. Creatine has shown protective effects in animal models of Parkinson's disease (preserving dopaminergic neurons), Huntington's disease (extending survival in transgenic mice by 9–18%), and ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig's disease – a progressive neurodegenerative condition affecting motor neurons) (Klopstock et al., Journal of Molecular Medicine, 2011; PMID 21387179). The proposed mechanism is consistent: creatine buffers the energy deficit that precedes cell death in metabolically stressed neurons.

The human trial results for neurodegenerative diseases have been mixed – a large Phase 3 trial for Parkinson's (NET-PD, 2015) did not show benefit. However, critics have noted that the trial used a standard dose that may not have been sufficient to meaningfully raise brain creatine levels, and that enrollment criteria included patients too far progressed for neuroprotection to be measurable. The question is not closed.

Depression and Mental Health

An emerging body of evidence connects brain bioenergetics to mood disorders. Kious et al. (2019) published a comprehensive review in Current Opinion in Psychiatry noting that creatine augmentation improved outcomes in treatment-resistant depression, particularly in women (PMID 31306245). Brain phosphocreatine levels measured by phosphorus magnetic resonance spectroscopy (31P-MRS – a brain imaging technique that measures energy metabolites directly) are reduced in major depressive disorder, and creatine supplementation has been shown to normalize these levels. The bioenergetic hypothesis of depression – that mood disorders partly reflect insufficient cellular energy in brain circuits – makes creatine a mechanistically rational intervention, not just an empirical one.

Sarcopenia Prevention: The Strongest Evidence-Based Intervention

Sarcopenia (age-related loss of skeletal muscle mass, strength, and function) is one of the primary drivers of frailty, disability, and mortality in older adults. After age 30, adults lose approximately 3–8% of muscle mass per decade, with the rate accelerating after 60. By 80, many individuals have lost 30–50% of their peak muscle mass.

The consequences extend far beyond aesthetics. Skeletal muscle is the body's largest metabolic organ – it regulates glucose disposal, systemic inflammation, and hormonal signaling. Muscle loss drives insulin resistance, increases fall risk, impairs immune function, and independently predicts all-cause mortality. See Exercise and Longevity: What Actually Works for the broader picture of why muscle is the organ of longevity.

The Chilibeck Meta-Analysis (2017)

Chilibeck and colleagues published a landmark meta-analysis in The Journal of Nutrition, Health & Aging examining creatine supplementation combined with resistance training in older adults (Chilibeck et al., 2017; PMID 28440249). The analysis pooled 22 RCTs with a total of 721 older adults (mean age ~65).

Key findings:

• Lean mass gains were significantly greater in creatine + resistance training groups vs. resistance training alone
• Upper body strength improved significantly more with creatine supplementation
• Lower body strength showed similar trends, though the effect was more variable across studies
• The improvements were clinically meaningful – exceeding the thresholds associated with reduced fall risk and maintained functional independence

A more recent meta-analysis by Candow et al. (2022) in the Journal of Cachexia, Sarcopenia and Muscle confirmed and expanded these findings: creatine plus resistance training increased lean tissue mass, chest press strength, and leg press strength significantly more than resistance training plus placebo in adults over 50 (PMID 35080159).

The clinical significance is straightforward: resistance training is the single most important physical intervention for sarcopenia, and creatine is the single most effective nutritional augmentation of that intervention. No other supplement has this volume of RCT evidence for muscle preservation in older adults.

Key Takeaway: Resistance training is the top intervention for age-related muscle loss, and creatine is the single most effective nutritional supplement to augment it — backed by 22+ RCTs in older adults showing significantly greater gains in lean mass and strength versus training alone. If you lift weights, creatine at 5g/day is one of the highest-confidence additions to your protocol.

Why Creatine Works for Aging Muscle

The mechanism goes beyond the phosphocreatine energy buffer. Creatine supplementation in older adults has been shown to:

1. Increase intramuscular phosphocreatine stores, improving training capacity and recovery between sets – which means more total training volume over time
2. Enhance satellite cell activation – satellite cells are muscle stem cells that fuse with damaged fibers during repair; creatine increases their proliferative capacity (Olsen et al., Journal of Physiology, 2006; PMID 16990401)
3. Upregulate IGF-1 expression locally in muscle tissue – IGF-1 (insulin-like growth factor 1) is a key anabolic (tissue-building) signaling molecule for muscle protein synthesis
4. Increase cell hydration through osmotic water retention in muscle cells, which itself acts as an anabolic signal via mTOR pathway activation

This last point is worth understanding: the water retention that bodybuilders sometimes complain about (1–2 kg of water weight gain) is not a side effect. It is the mechanism. Intracellular hydration stimulates protein synthesis. In older adults with declining anabolic capacity, this additional signal can be the difference between maintaining and losing functional muscle.

Mitochondrial Function: The Creatine Kinase Shuttle

The connection between creatine and mitochondria is more intimate than most people realize. The creatine kinase system does not merely buffer ATP at the site of use – it functions as a spatial energy transport system within the cell.

Here is how it works. Mitochondria produce ATP deep inside the cell. But the sites that consume ATP – myofibrils in muscle, ion pumps in neurons, contractile proteins in the heart – are often physically distant from mitochondria. Simply diffusing ATP across the cytoplasm (the gel-like interior of a cell) would be too slow and inefficient for high-demand tissues.

The solution is the creatine kinase shuttle (also called the phosphocreatine shuttle). A mitochondrial form of creatine kinase (Mi-CK) sits in the intermembrane space of the mitochondrion, directly coupled to the ATP/ADP translocator. It converts freshly made ATP into phosphocreatine, which diffuses rapidly through the cytoplasm to the site of energy demand. There, a cytosolic form of creatine kinase (CK-MM in muscle, CK-BB in brain) regenerates ATP from phosphocreatine on-site.

This shuttle system does something else critical: it maintains mitochondrial membrane potential. The mitochondrial membrane potential (the voltage difference across the inner mitochondrial membrane – the "charge" that drives ATP synthesis) depends on efficient ADP recycling. The Mi-CK enzyme ensures that ADP is rapidly returned to the mitochondrial matrix for re-phosphorylation, keeping the membrane potential stable and ATP production efficient (Schlattner et al., Biochimica et Biophysica Acta, 2006; PMID 16828729).

When creatine is depleted – whether through aging, dietary deficiency, or genetic conditions – this shuttle system operates below capacity. Mitochondria produce ATP that cannot be efficiently delivered, and ADP that cannot be efficiently recycled. The membrane potential fluctuates. Energy production becomes less efficient. Over time, mitochondria under bioenergetic stress accumulate damage and are flagged for degradation through mitophagy (the targeted destruction of damaged mitochondria).

Supplementing creatine does not fix damaged mitochondria. But it optimizes the function of existing ones by ensuring the shuttle system has adequate substrate. In a cell where mitochondrial function is already declining with age, maximizing the efficiency of remaining mitochondria is not a minor detail – it is a primary strategy. For the broader mitochondrial picture, see The Mitochondrial Theory of Aging: Everything Starts with Energy.

Key Takeaway: Creatine is not just a muscle supplement — it functions as a spatial energy transport system inside every cell, shuttling ATP from mitochondria to the sites that need it. As mitochondrial function declines with age, maximizing the efficiency of this shuttle becomes critical for brain, heart, and muscle performance.

Bone Health: Emerging Evidence for Postmenopausal Women

Bone loss accelerates dramatically after menopause due to declining estrogen, which normally suppresses osteoclast (bone-resorbing cell) activity. Osteoporosis affects approximately 200 million women worldwide, and hip fractures in the elderly carry a 20–30% one-year mortality rate.

The creatine-bone connection is less established than the muscle data but physiologically plausible and increasingly supported by clinical evidence.

Chilibeck et al. (2015) conducted a 12-month RCT in 33 postmenopausal women, comparing creatine + resistance training versus placebo + resistance training. The creatine group showed significantly reduced bone mineral density loss at the femoral neck (the most clinically relevant fracture site) compared to placebo (Chilibeck et al., Medicine & Science in Sports & Exercise, 2015; PMID 25386713).

A follow-up study (Chilibeck et al., 2020 – same group, longer duration) found that creatine combined with resistance training over 2 years preserved femoral shaft bone geometry (cortical thickness and section modulus) compared to placebo in postmenopausal women (PMID 33010918).

The proposed mechanisms:

1. Increased training volume – creatine allows more intense resistance training, which directly stimulates bone remodeling through mechanical loading
2. Enhanced osteoblast bioenergetics – osteoblasts (bone-building cells) are metabolically active and express creatine kinase; adequate creatine may support their energy-intensive bone formation activity
3. Reduced osteoclast activity – preliminary in vitro data suggests creatine may suppress osteoclast differentiation, though this requires more research

For women navigating perimenopause and postmenopause, creatine combined with resistance training addresses two of the most consequential aging trajectories – muscle loss and bone loss – simultaneously. See Longevity for Women Over 40: What Changes During Perimenopause for the broader context.

Anti-Inflammatory Effects: The Methylation Connection

Creatine biosynthesis consumes a substantial portion of the body's methyl groups. Approximately 40% of all SAMe (S-adenosylmethionine – the universal methyl donor in your body) is used for creatine synthesis in the liver. This means creatine synthesis competes with other methylation reactions, including the conversion of homocysteine (a sulfur-containing amino acid linked to cardiovascular disease and inflammation when elevated) to methionine.

When you supplement creatine exogenously (from an external source), you reduce the body's need to synthesize it internally. This frees up methyl groups for other critical methylation reactions – including DNA methylation (an epigenetic process that regulates gene expression), neurotransmitter synthesis, and homocysteine clearance.

Elevated homocysteine is an independent risk factor for cardiovascular disease, cognitive decline, and systemic inflammation. Multiple studies have shown that creatine supplementation reduces plasma homocysteine levels by 10–25% – a meaningful reduction that parallels the effects of B-vitamin supplementation (Deminice et al., Amino Acids, 2016; PMID 26553453).

Stead et al. (2001) demonstrated in rodent models that creatine supplementation reduced hepatic SAMe consumption by approximately 40%, freeing methyl groups for other metabolic needs (PMID 11160563). This "methyl-sparing" effect is particularly relevant for individuals with MTHFR polymorphisms (genetic variants that reduce the efficiency of folate metabolism – affecting an estimated 10–15% of the population) or those with marginal B-vitamin status.

The downstream anti-inflammatory effects are indirect but consistent: lower homocysteine, improved methylation capacity, and reduced inflammatory burden. For an in-depth look at how chronic low-grade inflammation drives aging, see Inflammaging: The Silent Fire Behind Every Age-Related Disease.

The Muscle Preservation Angle: Creatine in the GLP-1 Era

GLP-1 receptor agonists (a class of injectable medications originally developed for type 2 diabetes that produce significant weight loss – brand names include Ozempic, Wegovy, Mounjaro, and Zepbound) have become one of the most prescribed drug classes in the world. Their efficacy for weight loss and cardiometabolic risk reduction is well-established.

But up to 25–40% of the weight lost on GLP-1 agonists is lean body mass – predominantly skeletal muscle. For a 100 kg person losing 20 kg on semaglutide, that can mean 5–8 kg of lost muscle. In younger adults with ample muscle reserves, this is a manageable trade-off. In adults over 50 already experiencing sarcopenia, it can accelerate the very frailty that weight loss was supposed to prevent. See GLP-1 Drugs and Longevity: What the Data Actually Tells Us for the full analysis.

This has created an urgent question: how do you preserve muscle while losing fat on GLP-1 therapy?

The evidence-based answer has three components: adequate protein intake (1.2–1.6 g/kg/day – see Protein, mTOR, and Longevity: How Much Is Enough?), structured resistance training, and creatine supplementation. Of these, creatine is the only nutritional intervention with robust meta-analytic evidence for increasing lean mass retention during resistance training in older adults.

No randomized trial has yet specifically tested creatine in GLP-1-treated patients (as of early 2026). But the physiological rationale is strong:

1. GLP-1 agonists reduce appetite and caloric intake, creating an energy deficit that catabolic (tissue-breaking) pathways exploit
2. Creatine maintains intramuscular energy buffering during training performed in a caloric deficit
3. Creatine enhances satellite cell activation and local IGF-1 expression – anabolic signals that counteract catabolic pressure
4. Creatine increases intracellular hydration, an independent anabolic signal during energy restriction

Multiple research groups have called for RCTs specifically examining creatine co-supplementation during GLP-1 therapy. Until those data arrive, the mechanistic case and the existing sarcopenia meta-analyses make creatine a rational addition for anyone on GLP-1 medications who wants to minimize muscle loss.

Dosing: Simpler Than You Think

The effective dose of creatine monohydrate is 3–5 grams per day. That is it.

Loading vs. No Loading

Early creatine research used a "loading protocol" – 20 g/day (split into 4 doses of 5 g) for 5–7 days, followed by a maintenance dose of 3–5 g/day. Loading saturates muscle creatine stores in about a week. Without loading, the same saturation is achieved in approximately 3–4 weeks at the maintenance dose (Hultman et al., Journal of Applied Physiology, 1996; PMID 8941534).

For longevity purposes, there is no advantage to loading. The benefits of creatine for brain health, sarcopenia prevention, and mitochondrial support are chronic, not acute. Simply taking 3–5 g daily and allowing stores to saturate over a month is the practical recommendation.

Timing

Timing does not meaningfully matter for chronic supplementation. Some evidence suggests a modest advantage to post-workout ingestion (improved creatine uptake into recently exercised muscle), but the effect is small. Take it whenever you will consistently remember.

Form

Creatine monohydrate is the only form with robust clinical evidence. Marketing claims for creatine HCl, buffered creatine (Kre-Alkalyn), creatine ethyl ester, and creatine nitrate are not supported by comparative clinical trials. The ISSN position stand is explicit: no alternative form has demonstrated superiority to monohydrate (Kreider et al., JISSN, 2017).

Look for products certified by Informed Sport or NSF Certified for Sport, which verify purity and absence of contaminants.

Dose Adjustments

Some researchers have suggested weight-based dosing – roughly 0.03–0.07 g/kg body weight per day – which would mean larger individuals may benefit from the upper end of the 3–5 g range. For most adults, 5 g/day is a reasonable universal dose.

For vegetarians, vegans, and older adults (who may have lower baseline stores), 5 g/day is more likely to be necessary to achieve full saturation than 3 g/day.

Key Takeaway: Take 3-5g of creatine monohydrate daily — no loading phase needed, no special timing required, and no alternative form has proven superior. It is one of the most studied, safest, and most affordable supplements in existence. Skip the marketing hype around fancy creatine forms; monohydrate is the only version with robust clinical evidence. To see how creatine's evidence base stacks up against other longevity compounds, check the Compound Index.

Safety Note: Individuals with pre-existing kidney disease (CKD stages 3-5) should consult a nephrologist before supplementing creatine, as elevated creatinine will confound kidney function monitoring. If you take nephrotoxic medications, inform your physician about creatine use.

Safety: Debunking the Kidney Myth

The myth that creatine damages kidneys is arguably the most persistent piece of misinformation in sports nutrition. Here is what the evidence actually shows.

The Origin of the Myth

Creatine is metabolized to creatinine, which is filtered by the kidneys and used as a clinical marker of kidney function (the serum creatinine test). When someone takes creatine, their serum creatinine rises – not because their kidneys are failing, but because there is more creatine being metabolized. It is a measurement artifact, not a pathological finding.

This distinction was clarified decades ago. And yet the myth persists, repeated by physicians and fitness influencers alike who have confused a laboratory value with a disease state.

What 500+ Studies Show

Multiple systematic reviews have examined creatine and kidney function:

• Gualano et al. (2012) studied creatine in a patient with a single kidney – 12 weeks of supplementation produced no change in GFR (glomerular filtration rate – the standard measure of kidney function), cystatin C, or urinary protein levels (PMID 22691938)
• Poortmans and Francaux (2000) reviewed all available evidence and concluded that creatine does not impair renal function in healthy individuals at standard doses (PMID 10999421)
• A 2018 meta-analysis (de Souza e Silva et al.) confirmed no adverse renal effects across all examined RCTs (PMID 30032923)
• The ISSN position stand (2017) reviewed 500+ studies and stated: "There is no compelling scientific evidence that the short- or long-term use of creatine monohydrate has any detrimental effects on otherwise healthy individuals"

Who Should Be Cautious

Individuals with pre-existing kidney disease (Chronic Kidney Disease stages 3–5) should consult a nephrologist before supplementing creatine, not because creatine is known to worsen kidney disease, but because the elevated creatinine from supplementation will confound monitoring of disease progression. This is a clinical management issue, not a toxicity issue.

Other Safety Notes

• GI discomfort: Occurs occasionally at high doses (>10 g at once). Easily avoided by keeping daily intake at 3–5 g
• Water retention: 1–2 kg of water weight gain in the first 1–2 weeks is normal and reflects intramuscular hydration, not edema. This stabilizes and is not harmful
• Hair loss (DHT hypothesis): A single 2009 study in rugby players found creatine increased DHT (dihydrotestosterone) levels. This has never been replicated, and no study has directly measured hair loss from creatine supplementation. The evidence does not support this concern (Antonio et al., JISSN, 2021; PMID 33557850)
• No liver toxicity, no cardiovascular risk, no endocrine disruption has been observed in any controlled trial

Creatine monohydrate is one of the most extensively safety-tested supplements in existence. Its risk profile is, by any reasonable standard, exceptionally low.

Frequently Asked Questions

Related Reading

• The Mitochondrial Theory of Aging: Why Your Cellular Power Plants Matter
• CoQ10 Ubiquinol: The Mitochondrial Fuel Your Body Stops Making After 40
• Taurine and Aging: What the Science Actually Says
• Exercise and Longevity: What Actually Moves the Needle
• Glycine: The Simplest Amino Acid With the Biggest Longevity Impact
• Longevity for Women Over 40: Perimenopause, Hormones, and Cellular Aging
• Strength Training for Longevity: Why Muscle Is a Survival Organ

Citations:

• Harris RC et al. Elevation of creatine in resting and exercised muscle. Clinical Science. 1992. PMID 1327657
• Kreider RB et al. ISSN position stand: creatine supplementation. JISSN. 2017. PMID 28615996
• Avgerinos KI et al. Effects of creatine on cognition. Experimental Gerontology. 2018. PMID 29704637
• Forbes SC et al. Creatine and cognitive function. Nutrition Reviews. 2022. PMID 36220764
• McMorris T et al. Creatine and sleep deprivation. Psychopharmacology. 2006. PMID 16826400
• Sullivan PG et al. Creatine and neuroprotection. Annals of Neurology. 2000. PMID 10976075
• Sakellaris G et al. Creatine in pediatric TBI. 2006. PMID 16679861
• Kious BM et al. Creatine for depression. Current Opinion in Psychiatry. 2019. PMID 31306245
• Chilibeck PD et al. Creatine and aging meta-analysis. J Nutr Health Aging. 2017. PMID 28440249
• Candow DG et al. Creatine and aging update. J Cachexia Sarcopenia Muscle. 2022. PMID 35080159
• Olsen S et al. Creatine and satellite cells. J Physiol. 2006. PMID 16990401
• Schlattner U et al. Creatine kinase shuttle. BBA. 2006. PMID 16828729
• Chilibeck PD et al. Creatine and bone in postmenopausal women. MSSE. 2015. PMID 25386713
• Chilibeck PD et al. Creatine and bone geometry. 2020. PMID 33010918
• Deminice R et al. Creatine and homocysteine. Amino Acids. 2016. PMID 26553453
• Stead LM et al. Creatine and methylation. 2001. PMID 11160563
• Hultman E et al. Creatine loading. J Applied Physiol. 1996. PMID 8941534
• Gualano B et al. Creatine in single kidney. 2012. PMID 22691938
• Poortmans JR, Francaux M. Creatine and renal function. 2000. PMID 10999421
• de Souza e Silva A et al. Creatine and kidneys meta-analysis. 2018. PMID 30032923
• Antonio J et al. Creatine and DHT. JISSN. 2021. PMID 33557850

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.